SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-025602
Filing Date
2024-06-28
Accepted
2024-06-28 16:05:18
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1502
  Complete submission text file 0001493152-24-025602.txt   3145
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address
Friscia Stephen (Reporting) CIK: 0002028845 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36268 | Film No.: 241085649